Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis.

Nat Commun · 2023 · PMC10435464 · PMID 37591957

Europe PMC DOI

hedged sentence

0.0608

closest p · 1.2× alpha

0.0608

boldest claim

The sentences

nearly significantp = 0.0608so close (0.05 < p ≤ 0.1)

Comparison among correlation coefficients showed a nearly significant difference between rapamycin and placebo arm in serum NfL ( p = 0.0608); the difference was less pronounced for pNfH ( p = 0.1429).

also in 3,279 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.